These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14995903)

  • 1. Signature of a silent killer: expression profiling in epithelial ovarian cancer.
    Le Page C; Provencher D; Maugard CM; Ouellet V; Mes-Masson AM
    Expert Rev Mol Diagn; 2004 Mar; 4(2):157-67. PubMed ID: 14995903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene-expression profiling in epithelial ovarian cancer.
    Konstantinopoulos PA; Spentzos D; Cannistra SA
    Nat Clin Pract Oncol; 2008 Oct; 5(10):577-87. PubMed ID: 18648354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
    Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC
    Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling studies in ovarian cancer: a review.
    Fehrmann RS; Li XY; van der Zee AG; de Jong S; Te Meerman GJ; de Vries EG; Crijns AP
    Oncologist; 2007 Aug; 12(8):960-6. PubMed ID: 17766655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling of epithelial ovarian tumours correlated with malignant potential.
    Warrenfeltz S; Pavlik S; Datta S; Kraemer ET; Benigno B; McDonald JF
    Mol Cancer; 2004 Oct; 3():27. PubMed ID: 15471544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
    Tothill RW; Tinker AV; George J; Brown R; Fox SB; Lade S; Johnson DS; Trivett MK; Etemadmoghadam D; Locandro B; Traficante N; Fereday S; Hung JA; Chiew YE; Haviv I; ; Gertig D; DeFazio A; Bowtell DD
    Clin Cancer Res; 2008 Aug; 14(16):5198-208. PubMed ID: 18698038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for genes associated with ovarian cancer prognosis.
    Chang XH; Zhang L; Yang R; Feng J; Cheng YX; Cheng HY; Ye X; Fu TY; Cui H
    Chin Med J (Engl); 2009 May; 122(10):1167-72. PubMed ID: 19493465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGF axis gene expression patterns are prognostic of survival in epithelial ovarian cancer.
    Spentzos D; Cannistra SA; Grall F; Levine DA; Pillay K; Libermann TA; Mantzoros CS
    Endocr Relat Cancer; 2007 Sep; 14(3):781-90. PubMed ID: 17914107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression and prognostic significance in ovarian cancer.
    Tammela J; Odunsi K
    Minerva Ginecol; 2004 Dec; 56(6):495-502. PubMed ID: 15729202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling and prediction of clinical outcome in ovarian cancer.
    Sabatier R; Finetti P; Cervera N; Birnbaum D; Bertucci F
    Crit Rev Oncol Hematol; 2009 Nov; 72(2):98-109. PubMed ID: 19249225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.
    Lu L; Katsaros D; Wiley A; de la Longrais IA; Puopolo M; Yu H
    Cancer Invest; 2008 Mar; 26(2):185-92. PubMed ID: 18259951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.
    Bignotti E; Tassi RA; Calza S; Ravaggi A; Romani C; Rossi E; Falchetti M; Odicino FE; Pecorelli S; Santin AD
    Gynecol Oncol; 2006 Nov; 103(2):405-16. PubMed ID: 16725184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression.
    Motamed-Khorasani A; Jurisica I; Letarte M; Shaw PA; Parkes RK; Zhang X; Evangelou A; Rosen B; Murphy KJ; Brown TJ
    Oncogene; 2007 Jan; 26(2):198-214. PubMed ID: 16832351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells.
    Okamoto A; Nikaido T; Ochiai K; Takakura S; Saito M; Aoki Y; Ishii N; Yanaihara N; Yamada K; Takikawa O; Kawaguchi R; Isonishi S; Tanaka T; Urashima M
    Clin Cancer Res; 2005 Aug; 11(16):6030-9. PubMed ID: 16115948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
    Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH
    Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profiling and individualisation of treatment for ovarian cancer.
    Agarwal R; Kaye SB
    Curr Opin Pharmacol; 2006 Aug; 6(4):345-9. PubMed ID: 16750423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment.
    Barton CA; Hacker NF; Clark SJ; O'Brien PM
    Gynecol Oncol; 2008 Apr; 109(1):129-39. PubMed ID: 18234305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker.
    Huddleston HG; Wong KK; Welch WR; Berkowitz RS; Mok SC
    Gynecol Oncol; 2005 Jan; 96(1):77-83. PubMed ID: 15589584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monitoring novel ovarian carcinoma associated genes using cDNA expression microarray].
    Chang XH; Cheng YX; Zhang XY; Cui H; Feng J
    Zhonghua Fu Chan Ke Za Zhi; 2003 Jun; 38(6):322-4. PubMed ID: 12895369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BTF4/BTNA3.2 and GCS as candidate mRNA prognostic markers in epithelial ovarian cancer.
    Le Page C; Ouellet V; Quinn MC; Tonin PN; Provencher DM; Mes-Masson AM
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):913-20. PubMed ID: 18398031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.